Skip to main content
. 2020 Jun 30;8(2):e000779. doi: 10.1136/jitc-2020-000779

Figure 1 .


Figure 1

Enrollment of study subjects. ICI, immune checkpoint inhibitor; MM, malignant melanoma; NSCLC, non-small cell lung carcinoma; OS, overall survival.